Amalgamated Bank Acadia Pharmaceuticals Inc Transaction History

Amalgamated Bank

  • $13.6 Billion
  • Q3 2025

A detailed history of Amalgamated Bank transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 36,310 shares of ACAD stock, worth $812,254. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,310
Previous 35,091 3.47%
Holding current value
$812,254
Previous $756,000 2.38%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025
BUY
$20.88 - $26.57 $25,452 - $32,388
1,219 Added 3.47%
36,310 $774,000
Q2 2025

Aug 04, 2025
BUY
$14.1 - $22.95 $1,254 - $2,042
89 Added 0.25%
35,091 $756,000
Q1 2025

Apr 25, 2025
BUY
$16.61 - $20.29 $513,597 - $627,387
30,921 Added 757.68%
35,002 $581,000
Q4 2024

Feb 04, 2025
SELL
$14.29 - $18.76 $3,200 - $4,202
-224 Reduced 5.2%
4,081 $75,000
Q2 2024

Aug 12, 2024
BUY
$14.62 - $18.42 $2,777 - $3,499
190 Added 4.62%
4,305 $70,000
Q1 2024

Apr 23, 2024
SELL
$17.79 - $30.86 $237,425 - $411,857
-13,346 Reduced 76.43%
4,115 $76,000
Q4 2023

Feb 06, 2024
SELL
$20.78 - $31.77 $25,434 - $38,886
-1,224 Reduced 6.55%
17,461 $547,000
Q3 2023

Nov 08, 2023
BUY
$20.84 - $33.47 $5,751 - $9,237
276 Added 1.5%
18,685 $389,000
Q2 2023

Aug 11, 2023
BUY
$17.8 - $25.65 $24,332 - $35,063
1,367 Added 8.02%
18,409 $440,000
Q1 2023

May 02, 2023
SELL
$16.32 - $20.92 $46,316 - $59,370
-2,838 Reduced 14.28%
17,042 $321,000
Q4 2022

Feb 10, 2023
BUY
$14.2 - $18.63 $8,832 - $11,587
622 Added 3.23%
19,880 $316,000
Q3 2022

Nov 09, 2022
BUY
$14.11 - $18.27 $4,331 - $5,608
307 Added 1.62%
19,258 $315,000
Q2 2022

Aug 15, 2022
SELL
$13.01 - $27.22 $8,352 - $17,475
-642 Reduced 3.28%
18,951 $267,000
Q1 2022

Jun 30, 2022
SELL
$20.94 - $27.5 $30,802 - $40,452
-1,471 Reduced 6.98%
19,593 $475,000
Q4 2021

Feb 15, 2022
SELL
$16.79 - $27.09 $5,221 - $8,424
-311 Reduced 1.45%
21,064 $492,000
Q3 2021

Oct 29, 2021
SELL
$15.78 - $24.77 $19,377 - $30,417
-1,228 Reduced 5.43%
21,375 $355,000
Q2 2021

Aug 16, 2021
BUY
$19.4 - $27.42 $39,149 - $55,333
2,018 Added 9.8%
22,603 $551,000
Q1 2021

May 13, 2021
SELL
$25.02 - $54.99 $44,910 - $98,707
-1,795 Reduced 8.02%
20,585 $531,000
Q4 2020

Feb 12, 2021
SELL
$41.04 - $56.79 $41 - $56
-1 Reduced -0.0%
22,380 $0
Q3 2020

Oct 30, 2020
SELL
$36.42 - $57.0 $10,743 - $16,815
-295 Reduced 1.3%
22,381 $923,000
Q2 2020

Aug 10, 2020
BUY
$39.26 - $52.73 $100,584 - $135,094
2,562 Added 12.74%
22,676 $1.1 Million
Q1 2020

May 13, 2020
SELL
$31.65 - $46.87 $20,920 - $30,981
-661 Reduced 3.18%
20,114 $850,000
Q4 2019

Feb 13, 2020
BUY
$36.21 - $51.4 $74,846 - $106,243
2,067 Added 11.05%
20,775 $889,000
Q3 2019

Nov 13, 2019
SELL
$22.22 - $44.01 $4,866 - $9,638
-219 Reduced 1.16%
18,708 $673,000
Q2 2019

Aug 14, 2019
BUY
$23.32 - $28.12 $38,827 - $46,819
1,665 Added 9.65%
18,927 $506,000
Q1 2019

May 15, 2019
BUY
$16.17 - $27.38 $47,184 - $79,894
2,918 Added 20.34%
17,262 $463,000
Q4 2018

Feb 15, 2019
BUY
$14.32 - $22.92 $205,406 - $328,764
14,344 New
14,344 $232,000
Q3 2018

Nov 14, 2018
SELL
$13.03 - $21.81 $196,166 - $328,349
-15,055 Closed
0 $0
Q2 2018

Jul 18, 2018
SELL
$15.07 - $22.34 $89,907 - $133,280
-5,966 Reduced 28.38%
15,055 $230,000
Q1 2018

May 22, 2018
BUY
$22.47 - $32.33 $30,064 - $43,257
1,338 Added 6.8%
21,021 $472,000
Q4 2017

Feb 13, 2018
BUY
$26.84 - $39.14 $37,844 - $55,187
1,410 Added 7.72%
19,683 $593,000
Q3 2017

Nov 09, 2017
BUY
$29.49 - $38.37 $538,870 - $701,135
18,273
18,273 $688,000

Others Institutions Holding ACAD

# of Institutions
353
Shares Held
164M
Call Options Held
811K
Put Options Held
334K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.62B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email